Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?

被引:390
|
作者
Diepenbruck, Maren [1 ]
Christofori, Gerhard [1 ]
机构
[1] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
MIR-200; FAMILY; COLORECTAL-CANCER; TUMOR PROGRESSION; FEEDBACK LOOP; STEM-CELLS; DISSEMINATION; EXPRESSION; PLASTICITY; BETA; COLONIZATION;
D O I
10.1016/j.ceb.2016.06.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
An epithelial to mesenchymal transition (EMT) is a process of cell remodeling critical during embryonic development and organogenesis. During an EMT, epithelial cells lose their polarized organization and acquire migratory and invasive capabilities. While a plethora of experimental results have indicated that manipulating an EMT also affects cancer metastasis, its reverse process, a mesenchymal to epithelial transition (MET), seems to support metastatic outgrowth in distant organs. Moreover, recent reports investigating cancer cells circulating in the blood stream or employing genetic lineage-tracing have questioned a critical role of an EMT in metastasis formation. Hence, we need to better understand the molecular networks underlying the cell plasticity conferred by an EMT or a MET and its functional contribution to malignant tumor progression.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 50 条
  • [31] MicroRNA control of epithelial-mesenchymal transition and metastasis
    Zhang, Jinsong
    Ma, Li
    CANCER AND METASTASIS REVIEWS, 2012, 31 (3-4) : 653 - 662
  • [32] Epithelial-mesenchymal transition (EMT) in resected pancreatic cancer.
    Yosuico, V. D.
    Khoury, T.
    Yu, J.
    Pande, A.
    Javle, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 201S - 201S
  • [33] Epithelial-mesenchymal Transition (EMT) Molecular Biomarkers in Malignant IPMN
    Lahat, G. J.
    Lowenstein, S.
    Nachmany, I.
    Benhaim, M.
    Nakache, R.
    Santo, I.
    Inbar, M.
    Halperin, Z.
    Klausner, J. M.
    Lubezky, N.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S9 - S9
  • [34] Epithelial-Mesenchymal Transition (EMT) in Non Endometrioid Endometrial Carcinomas
    Montserrat, N.
    Llobet, D.
    Pons, C.
    Pena, J.
    Gallardo, A.
    Cuatrecasas, M.
    Dolcet, X.
    Matias-Guiu, X.
    Prat, J.
    MODERN PATHOLOGY, 2009, 22 : 229A - 229A
  • [35] Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
    Nathan J Zvaifler
    Arthritis Research & Therapy, 8
  • [36] Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?
    Kriz, Wilhelm
    Kaissling, Brigitte
    Le Hir, Michel
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (02): : 468 - 474
  • [37] Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases
    Zvaifler, Nathan J.
    ARTHRITIS RESEARCH & THERAPY, 2006, 8 (03)
  • [38] Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer
    Zhong, Weilong
    Sun, Tao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [39] Epithelial-Mesenchymal Transition (EMT) in Non Endometrioid Endometrial Carcinomas
    Montserrat, N.
    Llobet, D.
    Pons, C.
    Pena, J.
    Gallardo, A.
    Cuatrecasas, M.
    Dolcet, X.
    Matias-Guiu, X.
    Prat, J.
    LABORATORY INVESTIGATION, 2009, 89 : 229A - 229A
  • [40] Evidence of pazopanibinduced epithelial-mesenchymal transition (EMT) in human tumors
    Navas, Tony
    Srivastava, Apurva K.
    Ferry-Galow, Katherine
    Makhlouf, Hala
    Chuaqui, Rodrigo
    Kinders, Robert J.
    Bottaro, Donald P.
    Chen, Alice P.
    Parchment, Ralph E.
    Kummar, Shivaani
    Doroshow, James H.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)